A proteomic landscape of pharmacologic perturbations for functional relevance.

Authors:
Liu Z; Jiang S; Hao B; Xie S; Liu Y and 6 more

Journal:
J Pharm Anal

Publication Year: 2023

DOI:
10.1016/j.jpha.2023.08.021

PMCID:
PMC10859532

PMID:
38352953

Journal Information

Full Title: J Pharm Anal

Abbreviation: J Pharm Anal

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors declare that there are no conflicts of interest."

Evidence found in paper:

"This work was supported by the Natural Science Foundation of China (Grant Nos.: 22225702 and 32322048), the National Key R&D Program of China (Grant No.: 2020YFE0202200), the Shanghai Academic/Technology Research Leader Program, China (Grant No.: 22XD1420900), Guangdong High-level New R&D Institute, China (Grant No.:2019B090904008), Guangdong High-level Innovative Research Institute, China (Grant No.:2021B0909050003), the Shanghai Rising-Star Program, China (Grant No.: 22QA1411100), the Youth Innovation Promotion Association of the Chinese Academy of Sciences (Grant No.: 2021276), the Young Elite Scientists Sponsorship Program by China Association for Science and Technology, China (Grant No.: 2022QNRC001), and the open fund of State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, China (Grant No.: KF-202201). We also thank the support of the Innovative Research Team of High-Level Local Universities in Shanghai, China (Grant No.: SHSMU-ZDCX20212700) and Sanofi scholarship program."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025